Lene Mellemkjær
About
In The Last Decade
Lene Mellemkjær
204 papers receiving 11.1k citations
Hit Papers
Peers
Comparison fields: 5 of 148
- Oncology 2.6k
- Epidemiology 2.5k
- Surgery 1.9k
- Genetics 1.8k
- Pathology and Forensic Medicine 1.7k
Countries citing papers authored by Lene Mellemkjær
This map shows the geographic impact of Lene Mellemkjær's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lene Mellemkjær with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lene Mellemkjær more than expected).
Fields of papers citing papers by Lene Mellemkjær
This network shows the impact of papers produced by Lene Mellemkjær. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lene Mellemkjær. The network helps show where Lene Mellemkjær may publish in the future.
Co-authorship network of co-authors of Lene Mellemkjær
This figure shows the co-authorship network connecting the top 25 collaborators of Lene Mellemkjær. A scholar is included among the top collaborators of Lene Mellemkjær based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lene Mellemkjær. Lene Mellemkjær is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 3 | |
| 7 | 7 | |
| 8 | 7 | |
| 9 | 1 | |
| 10 | 7 | |
| 11 | 1 | |
| 12 | 5 | |
| 13 | 11 | |
| 14 | 17 | |
| 15 | Malignant progression of precancerous lesions of the uterine cervix following DMARD therapy in female arthritis patients. | 1 |
| 16 | No increased cancer risk in patients with rheumatoid arthritis, psoriatic arthritis or other arthritides treated with anti-tumor necrosis factor agents - A long-term follow-up study from the nationwide Danish Danbio Registry | 1 |
| 17 | 126 | |
| 18 | Angiotensin-converting enzyme inhibitors and risk of cancer - A population-based cohort study in Denmark | 8 |
| 19 | 239 | |
| 20 | 58 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.